arotinolol
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Apr 1, 2011 (NCT01351636)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
- Adrenergic receptor betaANTAGONIST
Adrenergic receptor beta antagonist
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1- Mol. weight
- 371.55 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL93298 ↗
Also known as
- 2-(3'-tert-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole hydrochloride
- 5-(2-((3-((1,1-dimethylethyl)amino)-2-hydroxypropyl)thio)-4-thiazolyl)-2-thiophenecarboxamide
- arotinolol
- arotinolol
- arotinolol
- arotinolol
- arotinolol
- arotinolol
- arotinolol
- arotinolol hcl
- arotinolol hcl
- arotinolol hcl
- arotinolol hydrochloride
- arotinolol hydrochloride
- arotinolol hydrochloride
- arotinolol hydrochloride
- arotinolol, (+-)-isomer
- s 596
- s-596
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02612298 | Phase 4 | Aug 1, 2015 | People's Liberation Army of China, Sumitomo |
| NCT01351636 | Phase 4 | Apr 1, 2011 | Jiao Tong University, Sumitomo |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sumitomo | For profit | 2 | 2 | 1 | 2011 |
| Jiao Tong University | Academic/Hospital | 1 | 0 | 1 | 2011 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2015 |
3 organizations
Page 1 / 1